Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes.


Journal

European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263

Informations de publication

Date de publication:
21 03 2021
Historique:
received: 11 04 2020
revised: 10 07 2020
accepted: 10 11 2020
pubmed: 14 1 2021
medline: 29 5 2021
entrez: 13 1 2021
Statut: ppublish

Résumé

There is inconsistent evidence on the relation of alcohol intake with incident atrial fibrillation (AF), in particular at lower doses. We assessed the association between alcohol consumption, biomarkers, and incident AF across the spectrum of alcohol intake in European cohorts. In a community-based pooled cohort, we followed 107 845 individuals for the association between alcohol consumption, including types of alcohol and drinking patterns, and incident AF. We collected information on classical cardiovascular risk factors and incident heart failure (HF) and measured the biomarkers N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin I. The median age of individuals was 47.8 years, 48.3% were men. The median alcohol consumption was 3 g/day. N = 5854 individuals developed AF (median follow-up time: 13.9 years). In a sex- and cohort-stratified Cox regression analysis alcohol consumption was non-linearly and positively associated with incident AF. The hazard ratio for one drink (12 g) per day was 1.16, 95% CI 1.11-1.22, P < 0.001. Associations were similar across types of alcohol. In contrast, alcohol consumption at lower doses was associated with reduced risk of incident HF. The association between alcohol consumption and incident AF was neither fully explained by cardiac biomarker concentrations nor by the occurrence of HF. In contrast to other cardiovascular diseases such as HF, even modest habitual alcohol intake of 1.2 drinks/day was associated with an increased risk of AF, which needs to be considered in AF prevention.

Identifiants

pubmed: 33438022
pii: 6090248
doi: 10.1093/eurheartj/ehaa953
pmc: PMC7982286
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1170-1177

Subventions

Organisme : Medical Research Council
ID : G0601463
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : ErratumIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Clin Chem. 2016 Sep;62(9):1202-10
pubmed: 27440513
Europace. 2017 Mar 1;19(3):346-355
pubmed: 27302393
Eur Heart J. 2016 Oct 7;37(38):2893-2962
pubmed: 27567408
J Am Coll Cardiol. 2017 Jan 3;69(1):13-24
pubmed: 28057245
J Am Coll Cardiol. 2019 Dec 3;74(22):2771-2781
pubmed: 31779791
Am Heart J. 2014 Jan;167(1):109-115.e2
pubmed: 24332149
Eur Heart J. 2015 Apr 14;36(15):939-45
pubmed: 25602025
JACC Heart Fail. 2017 Nov;5(11):837-844
pubmed: 29032141
J Am Heart Assoc. 2017 Oct 20;6(10):
pubmed: 29054845
Eur Heart J. 2017 Jul 14;38(27):2100-2106
pubmed: 28449090
Europace. 2020 Feb 1;22(2):216-224
pubmed: 31620800
J Am Heart Assoc. 2016 Sep 14;5(9):
pubmed: 27628571
Am J Med. 2015 May;128(5):509-18.e2
pubmed: 25534423
J Am Coll Cardiol. 2011 Jan 25;57(4):427-36
pubmed: 21251583
BMJ. 2017 Mar 22;356:j909
pubmed: 28331015
Circulation. 2005 Sep 20;112(12):1736-42
pubmed: 16157768
Am Heart J. 2007 Feb;153(2):260-6
pubmed: 17239687
Lancet. 2018 Apr 14;391(10129):1513-1523
pubmed: 29676281
N Engl J Med. 2020 Jan 2;382(1):20-28
pubmed: 31893513
Int J Cardiol. 2017 Nov 1;246:46-52
pubmed: 28867013
Circulation. 2017 Aug 8;136(6):583-596
pubmed: 28784826
Nutr Metab Cardiovasc Dis. 2019 Jul;29(7):676-683
pubmed: 31078364
Eur J Epidemiol. 2014 Oct;29(10):777-90
pubmed: 25238720
J Am Coll Cardiol. 2014 Jul 22;64(3):281-9
pubmed: 25034065
BMJ. 2015 Feb 10;350:h384
pubmed: 25670624
Arch Intern Med. 2006 Dec 11-25;166(22):2437-45
pubmed: 17159008
J Am Coll Cardiol. 2016 Dec 13;68(23):2567-2576
pubmed: 27931615
PLoS One. 2017 Oct 18;12(10):e0185228
pubmed: 29045461
JAMA. 2008 Dec 3;300(21):2489-96
pubmed: 19050192

Auteurs

Dora Csengeri (D)

Department of Cardiology, University Heart & Vascular Center Hamburg, Martinistraße 52, 20246 Hamburg, Germany.

Ngoc-Anh Sprünker (NA)

Department of Cardiology, University Heart & Vascular Center Hamburg, Martinistraße 52, 20246 Hamburg, Germany.

Augusto Di Castelnuovo (A)

Mediterranea Cardiocentro, Via Orazio 2, 80122 Napoli, Italy.

Teemu Niiranen (T)

Division of Medicine, Turku University Hospital and University of Turku, Kiinamyllynkatu 4-8, 20521 Turku, Finland.
Department of Public Health Solutions, Finnish Institute for Health and Welfare, POB 30, Mannerheimintie 166, 00271 Helsinki, Finland.

Julie Kk Vishram-Nielsen (JK)

Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark, Nordre Fasanvej 57, 2000 Frederiksberg, Denmark.
Department of Cardiology, Righospitalet, University Hospital of Copenhagen, Blegdamsvej 9, 2100 Copenhagen Denmark.

Simona Costanzo (S)

Department of Epidemiology and Prevention, IRCCS Neuromed, Via dell´ Elettronica, 86077 Pozzilli, Italy.

Stefan Söderberg (S)

Department of Public Health and Clinical Medicine, and Heart Centre, Umeå University, SE-901 87 Umeå, Sweden.

Steen M Jensen (SM)

Department of Public Health and Clinical Medicine, and Heart Centre, Umeå University, SE-901 87 Umeå, Sweden.

Erkki Vartiainen (E)

Department of Public Health Solutions, Finnish Institute for Health and Welfare, POB 30, Mannerheimintie 166, 00271 Helsinki, Finland.

Maria Benedetta Donati (MB)

Department of Epidemiology and Prevention, IRCCS Neuromed, Via dell´ Elettronica, 86077 Pozzilli, Italy.

Christina Magnussen (C)

Department of Cardiology, University Heart & Vascular Center Hamburg, Martinistraße 52, 20246 Hamburg, Germany.
German Centre for Cardiovascular Research (DZHK), partner site, Hamburg/Kiel/Luebeck, Potsdamer Straße 58, 10785 Berlin, Germany.

Stephan Camen (S)

Department of Cardiology, University Heart & Vascular Center Hamburg, Martinistraße 52, 20246 Hamburg, Germany.
German Centre for Cardiovascular Research (DZHK), partner site, Hamburg/Kiel/Luebeck, Potsdamer Straße 58, 10785 Berlin, Germany.

Francesco Gianfagna (F)

Mediterranea Cardiocentro, Via Orazio 2, 80122 Napoli, Italy.
Research Center in Epidemiology and Preventive Medicine (EPIMED), Department of Medicine and Surgery, University of Insubria, Via Rossi 9, 21100 Varese, Italy.

Maja-Lisa Løchen (ML)

Department of Community Medicine, UiT The Arctic University of Norway, Hansine Hansens veg 18, 9019 Tromsø, Norway.

Frank Kee (F)

Center for Public Health, Institute of Clinical Sciences A, Queens University, Grosvenor Road, BT 12 6BJ Belfast, Ireland.

Jukka Kontto (J)

Department of Public Health Solutions, Finnish Institute for Health and Welfare, POB 30, Mannerheimintie 166, 00271 Helsinki, Finland.

Ellisiv B Mathiesen (EB)

Brain and Circulation Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, Hansine Hansens veg 18, 9019 Tromsø, Norway.

Wolfgang Koenig (W)

Deutsches Herzzentrum München, Lazarettstraße 36, 80636 Munich, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Biedersteinerstraße 29, 80802 Munich, Germany.
Institute of Epidemiology and Medial Biometry, University of Ulm, Helmholtzstraße 22, 89081 Ulm, Germany.

Blankenberg Stefan (B)

Department of Cardiology, University Heart & Vascular Center Hamburg, Martinistraße 52, 20246 Hamburg, Germany.
German Centre for Cardiovascular Research (DZHK), partner site, Hamburg/Kiel/Luebeck, Potsdamer Straße 58, 10785 Berlin, Germany.

Giovanni de Gaetano (G)

Department of Epidemiology and Prevention, IRCCS Neuromed, Via dell´ Elettronica, 86077 Pozzilli, Italy.

Torben Jørgensen (T)

Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark, Nordre Fasanvej 57, 2000 Frederiksberg, Denmark.
Department of Public Health, Faculty of Health and Medical Science, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.
Faculty of Medicine, Aalborg University, Niels Jernes Vej 10, 9220 Aalborg, Denmark.

Kari Kuulasmaa (K)

Department of Public Health Solutions, Finnish Institute for Health and Welfare, POB 30, Mannerheimintie 166, 00271 Helsinki, Finland.

Tanja Zeller (T)

Department of Cardiology, University Heart & Vascular Center Hamburg, Martinistraße 52, 20246 Hamburg, Germany.

Veikko Salomaa (V)

Department of Public Health Solutions, Finnish Institute for Health and Welfare, POB 30, Mannerheimintie 166, 00271 Helsinki, Finland.

Licia Iacoviello (L)

Department of Epidemiology and Prevention, IRCCS Neuromed, Via dell´ Elettronica, 86077 Pozzilli, Italy.
Research Center in Epidemiology and Preventive Medicine (EPIMED), Department of Medicine and Surgery, University of Insubria, Via Rossi 9, 21100 Varese, Italy.

Renate B Schnabel (RB)

Department of Cardiology, University Heart & Vascular Center Hamburg, Martinistraße 52, 20246 Hamburg, Germany.
German Centre for Cardiovascular Research (DZHK), partner site, Hamburg/Kiel/Luebeck, Potsdamer Straße 58, 10785 Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH